Monte Rosa Therapeutics
GLUE
GLUE
57 hedge funds and large institutions have $375M invested in Monte Rosa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $560M → $375M (-$185M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.17M | |
| 2 | +$1.78M | |
| 3 | +$983K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$786K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$703K |
Top Sellers
| 1 | -$7.56M | |
| 2 | -$7.15M | |
| 3 | -$4.35M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.14M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$984K |